Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy.

Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy. Front Microbiol. 2014; 5:303.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.